← #nieuws

HollandBIO welcomes AxTalis as a new member

HollandBIO connects, represents and supports the Dutch life science sector. We are very proud that we already represent over 270 companies: from start-ups, small and medium-sized companies to large companies, active in health, food or biobased economy. Today we welcome AxTalis, a consulting company that focuses on Market Access, Regulatory Affairs and Medical Affairs to support strategies and early launch implementation for academia, pharmaceutical and device companies.

AxTalis’ vision is to broaden the perspectives of patients to access drugs in a sustainable manner by collaborating closely with physicians, researchers, companies, payers and patients.

Market Access services include strategy development, pricing, and reimbursement dossiers, HEOR and Managed Entry agreements.  Flexible staffing allows us to provide temporary FTEs to companies on a time or project basis. We have extensive experience in all kind of procedures including but not limiting to Sluis, Ad on, CleanTeam/Ciebag, GVS 1A/1B.

Medical Affairs Services include medical writing, support for training development and implementation, stakeholder interaction & advisory boards, project development and implementation (early access, data generation/RWE, speaker programs, patient support programs). The creation and production of medical and promotional materials are supported by our ‘RIP’ activity and print service.

Regulatory Affairs services include healthcare policy and all aspects related to obtaining and maintaining registration of therapeutic solutions.  We also have a dedicated team that supports companies with pharmacovigilance and medical information.

AxTalis comprises of 14 valued professionals that work closely together as an additional cross-functional team with our clients. In the Netherlands Market Access Director Melanie van Riemsdijk is your point of contact.

Melanie has over 20 years of experience in Market Access in both Pharma and MedTech in the Netherlands. The majority of her activities have been focused on the Dutch Market, however, she has also experience in Global Market Access and Real World Evidence strategy. She has an extensive network of stakeholders in both clinical and governmental stakeholders and always willing to go the extra mile to ensure patient access to innovation.

E: melanie.vanriemsdijk@axtalis.com

M: +31 6 53841318

W: www.axtalis.com